Compare AUPH & CLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUPH | CLB |
|---|---|---|
| Founded | 1993 | 1936 |
| Country | Canada | United States |
| Employees | N/A | 3300 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 414.2M |
| IPO Year | 2014 | 2023 |
| Metric | AUPH | CLB |
|---|---|---|
| Price | $15.85 | $9.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $18.29 | $15.00 |
| AVG Volume (30 Days) | ★ 862.3K | 625.5K |
| Earning Date | 10-30-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 0.44% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.76 | 0.23 |
| Revenue | $283,055,000.00 | ★ $526,520,000.00 |
| Revenue This Year | $16.65 | N/A |
| Revenue Next Year | $17.73 | $2.52 |
| P/E Ratio | ★ $21.29 | $39.30 |
| Revenue Growth | N/A | ★ 0.51 |
| 52 Week Low | $13.52 | $8.61 |
| 52 Week High | $19.25 | $20.36 |
| Indicator | AUPH | CLB |
|---|---|---|
| Relative Strength Index (RSI) | 41.44 | 36.26 |
| Support Level | $15.67 | N/A |
| Resistance Level | $16.48 | $10.76 |
| Average True Range (ATR) | 0.55 | 0.42 |
| MACD | -0.11 | -0.06 |
| Stochastic Oscillator | 6.56 | 20.23 |
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.